Truist reiterates ServiceTitan stock rating on product expansion

Truist reiterated its Buy rating and $100 price target for ServiceTitan, citing Max expansion, pricing and packaging changes, and the Homh discovery platform as potential multi-year growth catalysts. The stock is down 35.5% year to date and trades 37% below its 52-week high; several analysts maintain Buy ratings, while Stifel cut its target from $125 to $100 after a 2.7% revenue beat fell short of its expectations.

Analysis

The debate is not whether ServiceTitan can ship more AI features; it is whether those features create incremental, paid workflow value rather than becoming a costly bundle needed to defend retention. Max could lift revenue per contractor if adoption supports higher-tier packaging, while Homh’s consumer-demand channel could make ServiceTitan more valuable to contractors—but also introduces customer-acquisition and marketplace execution risk. Neither product’s launch establishes conversion, unit economics, or durable pricing power.

Near term (days to 1–3 months), the cluster of bullish ratings may cushion sentiment, but leaves the stock vulnerable if upcoming results show continued deceleration or fail to clarify the second-quarter accounting questions. A smaller-than-usual beat matters if investors had expected the historical outperformance pattern to continue. Over 6–18 months, the key upside proof is paid Max adoption, expansion in average revenue per customer, and improving cash-flow conversion without deterioration in retention or implementation costs. Contractor demand is exposed to local repair/remodel activity and business confidence, so software growth is not immune to a weaker end market.

Contrarian angle: the drawdown may look like an entry point, but analyst targets and an asserted “unfair” selloff are not evidence of mispricing. Conversely, a market focused on near-term growth may underappreciate the potential value of owning both contractor workflow and consumer demand discovery—if Homh demonstrably delivers qualified leads. The thesis fails if product usage does not translate into paid expansion, growth guidance is cut, or cash-flow progress lags subscription growth.

Key Decisions for Investors

• Do not buy solely on the $100 analyst target. Treat TTAN as a watch-to-own: consider a staged long only after results or company disclosures show paid Max uptake, customer expansion, and cash-flow progress.
• For the next 1–3 months, monitor the next earnings release and management commentary for the accounting clarification, revenue-growth trajectory, and any change to guidance. A further slowdown or guidance reduction would invalidate the near-term recovery thesis.
• Track Max and Homh separately: seek evidence of paid conversion, customer adoption, lead quality, and incremental revenue versus implementation or acquisition costs. Until those metrics are disclosed, treat the AI and marketplace upside as optionality, not base-case value.
• For a 6–18 month long thesis, require expansion in average revenue per customer alongside stable retention and improving cash conversion. If growth depends mainly on packaging changes without demonstrable adoption, reduce exposure rather than assuming pricing power.